Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New developments in the pathology of malignant lymphoma: a review of the literature published from October 2009 to January 2010.

Literature DB >> 21633487

New developments in the pathology of malignant lymphoma: a review of the literature published from October 2009 to January 2010.

J Han van Krieken¹.

Abstract

Entities: Disease

Year: 2010 PMID： 21633487 PMCID： PMC2883905 DOI： 10.1007/s12308-010-0060-x

Source DB: PubMed Journal: J Hematop ISSN： 1865-5785 Impact factor: 0.196

Keyword Cloud
References

× No keyword cloud information.

78 in total

1. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

Authors: Matija Snuderl; Olga K Kolman; Yi-Bin Chen; Jessie J Hsu; Adam M Ackerman; Paola Dal Cin; Judith A Ferry; Nancy Lee Harris; Robert P Hasserjian; Lawrence R Zukerberg; Jeremy S Abramson; Ephraim P Hochberg; Hang Lee; Alfred I Lee; Christiana E Toomey; Aliyah R Sohani
Journal: Am J Surg Pathol Date: 2010-03 Impact factor: 6.394

2. gammadelta T lymphocytes count is normal and expandable in peripheral blood of patients with follicular lymphoma, whereas it is decreased in tumor lymph nodes compared with inflammatory lymph nodes.

Authors: Mounia Sabrina Braza; Anouk Caraux; Thérèse Rousset; Sylvie Lafaye de Micheaux; Hélène Sicard; Patrick Squiban; Valérie Costes; Bernard Klein; Jean-François Rossi
Journal: J Immunol Date: 2009-11-30 Impact factor: 5.422

3. Role of endoscopic ultrasound-guided fine-needle aspiration with flow cytometry to diagnose lymphoma: a single center experience.

Authors: Mohammad Al-Haddad; Mojgan Sara Savabi; Stuart Sherman; Lee McHenry; Julia Leblanc; Harvey Cramer; Robert Emerson; Jillian O'Neil; Mouen Khashab; John Dewitt
Journal: J Gastroenterol Hepatol Date: 2009-12 Impact factor: 4.029

4. Long-term follow-up of patients with newly diagnosed follicular lymphoma in the prerituximab era: effect of response quality on survival--A study from the groupe d'etude des lymphomes de l'adulte.

Authors: Emmanuel Bachy; Pauline Brice; Richard Delarue; Nicole Brousse; Corinne Haioun; Steven Le Gouill; Alain Delmer; Dominique Bordessoule; Hervé Tilly; Bernadette Corront; Christian Allard; Charles Foussard; André Bosly; Bertrand Coiffier; Christian Gisselbrecht; Philippe Solal-Celigny; Gilles Salles
Journal: J Clin Oncol Date: 2009-12-21 Impact factor: 44.544

New developments in the pathology of malignant lymphoma: a review of the literature published from October 2009 to January 2010.

1. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

2. gammadelta T lymphocytes count is normal and expandable in peripheral blood of patients with follicular lymphoma, whereas it is decreased in tumor lymph nodes compared with inflammatory lymph nodes.

3. Role of endoscopic ultrasound-guided fine-needle aspiration with flow cytometry to diagnose lymphoma: a single center experience.

4. Long-term follow-up of patients with newly diagnosed follicular lymphoma in the prerituximab era: effect of response quality on survival--A study from the groupe d'etude des lymphomes de l'adulte.

5. Expression of sphingosine-1-phosphate receptor 1 in mantle cell lymphoma.

6. Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins.

7. Epstein-Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b.

8. Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas.

9. Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma: a study of 51 cases.

10. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.